Search results
Results from the WOW.Com Content Network
The Nigerian subsidiary, bought out in 2002, remains as May & Baker Nigeria plc. [5] Later on, a further merger with Sanofi-Synthélabo in 2004 changed the Dagenham site owner to Sanofi-Aventis. In 2009 Sanofi-Aventis announced their intention to close the Dagenham plant by 2013. [6]
Unsourced material may be challenged and removed. Find sources: "Pharmaceutical industry in Nigeria" – news · newspapers · books · scholar · JSTOR ( June 2017 ) ( Learn how and when to remove this message )
In 2019 May & Baker Nigeria Plc has appointed Dr. Samuel Maduka Onyishi as its new Non-Executive Director. He was appointed during the company's 2019 Annual General Meeting (AGM). Sequel to the appointment, he has also been recommended by May & Baker's board for election as a Director of the company.
Petrol production at Nigerian business tycoon Aliko Dangote’s $20bn (£15.5bn) state-of-the-art oil refinery ought to be some of the best business news Nigeria has had in years.
Fidson Healthcare Plc produces painkillers, anti-allergies, blood pressure medicines, digestive aids, sleeping pills and cough syrup. [104] May & Baker Nig. Plc produces remedies against malaria, hypertension, diabetes, depressions and pain. [105] Swiss Pharma Nigeria produces pharmaceutical products of BAYER. [106] Innoson Vehicle ...
The National Park Service reported seven home collapses in Rodanthe in 2024, all happening since May. One unoccupied house on May 28 around 2:30 a.m. One unoccupied house on Aug. 16 at around 6:50 ...
Main page; Contents; Current events; Random article; About Wikipedia; Contact us; Pages for logged out editors learn more
M&B 693 was one of the first generation of sulfonamide antibiotics. It was discovered by Lionel Whitby at the British firm May & Baker Ltd and logged in their Test Book on 2 November, 1937 under Code No M&B 693.